Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Big Pharma to benefit from growth in diabetes: S&P
Big Pharma to benefit from growth in diabetes: S&P
Big Pharma to benefit from growth in diabetes: S&P
Submitted by
admin
on October 5, 2012 - 11:18am
Source:
Marketwatch
News Tags:
diabetes
Big Pharma
Eli Lilly
Merck
Bristol-Myers Squibb
Headline:
Big Pharma to benefit from growth in diabetes: S&P
Do Not Allow Advertisers to Use My Personal information
